415 related articles for article (PubMed ID: 22101215)
21. Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study.
Poole CD; Chambers C; Sidhu MK; Currie CJ
Br J Dermatol; 2009 Dec; 161(6):1335-40. PubMed ID: 19754867
[TBL] [Abstract][Full Text] [Related]
22. Tacrolimus 0.1% ointment for seborrhoeic dermatitis: an open-label pilot study.
Braza TJ; DiCarlo JB; Soon SL; McCall CO
Br J Dermatol; 2003 Jun; 148(6):1242-4. PubMed ID: 12828755
[TBL] [Abstract][Full Text] [Related]
23. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
24. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids.
Kirsner RS; Heffernan MP; Antaya R
Acta Derm Venereol; 2010; 90(1):58-64. PubMed ID: 20107727
[TBL] [Abstract][Full Text] [Related]
25. Comparing tacrolimus ointment and oral cyclosporine in adult patients affected by atopic dermatitis: a randomized study.
Pacor ML; Di Lorenzo G; Martinelli N; Mansueto P; Rini GB; Corrocher R
Clin Exp Allergy; 2004 Apr; 34(4):639-45. PubMed ID: 15080819
[TBL] [Abstract][Full Text] [Related]
26. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
Elewski B
Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacies of topical agents for the treatment of seborrheic dermatitis of the scalp: a comparative study.
Shin H; Kwon OS; Won CH; Kim BJ; Lee YW; Choe YB; Ahn KJ; Eun HC
J Dermatol; 2009 Mar; 36(3):131-7. PubMed ID: 19335686
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus ointment for the treatment of severe facial plaque psoriasis.
Kroft EB; Erceg A; Maimets K; Vissers W; van der Valk PG; van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):249-51. PubMed ID: 15752305
[TBL] [Abstract][Full Text] [Related]
29. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
30. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
31. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
Langtry JA; Rowland Payne CM; Staughton RC; Stewart JC; Horrobin DF
Clin Exp Dermatol; 1997 Sep; 22(5):216-9. PubMed ID: 9536541
[TBL] [Abstract][Full Text] [Related]
32. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone butyrate ointment in adult patients with atopic dermatitis.
Reitamo S; Rustin M; Ruzicka T; Cambazard F; Kalimo K; Friedmann PS; Schoepf E; Lahfa M; Diepgen TL; Judodihardjo H; Wollenberg A; Berth-Jones J; Bieber T;
J Allergy Clin Immunol; 2002 Mar; 109(3):547-55. PubMed ID: 11898005
[TBL] [Abstract][Full Text] [Related]
34. Topical pimecrolimus 1% cream for resistant seborrheic dermatitis of the face: an open-label study.
Ozden MG; Tekin NS; Ilter N; Ankarali H
Am J Clin Dermatol; 2010; 11(1):51-4. PubMed ID: 20000875
[TBL] [Abstract][Full Text] [Related]
35. Safe and effective treatment of refractory facial lesions in atopic dermatitis using topical tacrolimus following corticosteroid discontinuation.
Kawakami T; Soma Y; Morita E; Koro O; Yamamoto S; Nakamura K; Tamaki K; Yajima K; Imaizumi A; Matsunaga R; Murakami N; Kashima M; Mizoguchi M
Dermatology; 2001; 203(1):32-7. PubMed ID: 11549797
[TBL] [Abstract][Full Text] [Related]
36. Pimecrolimus cream 1% can be an effective treatment for seborrheic dermatitis of the face and trunk.
Rallis E; Nasiopoulou A; Kouskoukis C; Koumantaki E
Drugs Exp Clin Res; 2004; 30(5-6):191-5. PubMed ID: 15700745
[TBL] [Abstract][Full Text] [Related]
37. Adult patients with moderate atopic dermatitis: tacrolimus ointment versus pimecrolimus cream.
Abramovits W; Fleischer AB; Jaracz E; Breneman D
J Drugs Dermatol; 2008 Dec; 7(12):1153-8. PubMed ID: 19137769
[TBL] [Abstract][Full Text] [Related]
38. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
[TBL] [Abstract][Full Text] [Related]
39. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle.
Breneman D; Fleischer AB; Abramovits W; Zeichner J; Gold MH; Kirsner RS; Shull TF; Crowe AW; Jaracz E; Hanifin JM;
J Am Acad Dermatol; 2008 Jun; 58(6):990-9. PubMed ID: 18359127
[TBL] [Abstract][Full Text] [Related]
40. The treatment of inflammatory facial dermatoses with topical corticosteroids: focus on clocortolone pivalate 0.1% cream.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2012 Oct; 11(10):1194-8. PubMed ID: 23134984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]